Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon C Johnson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|December 6, 2014
Translational Medicine. A target for pharmacological intervention in an untreatable human diseaseSimon C Johnson
Sub-Cellular Biochemistry|February 20, 2019
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related DiseaseSimon C Johnson
Oncotarget|July 8, 2016
Rapamycin in aging and disease: maximizing efficacy while minimizing side effectsSimon C Johnson, Matt Kaeberlein
Orphanet Journal of Rare Diseases|September 2, 2022
The immune system as a driver of mitochondrial disease pathogenesis: a review of evidenceAllison Hanaford, Simon C Johnson
Mitochondrion|August 2, 2020
Mitochondrial pathways in human health and agingRebecca Bornstein, Brenda Gonzalez, Simon C Johnson
Nature|January 18, 2013
mTOR is a key modulator of ageing and age-related diseaseSimon C Johnson, Peter S Rabinovitch, Matt Kaeberlein
Aging Cell|June 17, 2015
Genetic evidence for common pathways in human age-related diseasesSimon C Johnson, Xiao Dong, Jan Vijg, et al.
Interdisciplinary Topics in Gerontology|October 25, 2014
Modulating mTOR in aging and healthSimon C Johnson, Maya Sangesland, Matt Kaeberlein, et al.
Science Translational Medicine|November 15, 2013
Preserving youth: does rapamycin deliver?Simon C Johnson, George M Martin, Peter S Rabinovitch, et al.
Neurotoxicology and Teratology|November 26, 2018
Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studiesSimon C Johnson, Amanda Pan, Li Li, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|December 6, 2014
Translational Medicine. A target for pharmacological intervention in an untreatable human diseaseSimon C Johnson
Sub-Cellular Biochemistry|February 20, 2019
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related DiseaseSimon C Johnson
Oncotarget|July 8, 2016
Rapamycin in aging and disease: maximizing efficacy while minimizing side effectsSimon C Johnson, Matt Kaeberlein
Orphanet Journal of Rare Diseases|September 2, 2022
The immune system as a driver of mitochondrial disease pathogenesis: a review of evidenceAllison Hanaford, Simon C Johnson
Mitochondrion|August 2, 2020
Mitochondrial pathways in human health and agingRebecca Bornstein, Brenda Gonzalez, Simon C Johnson
Nature|January 18, 2013
mTOR is a key modulator of ageing and age-related diseaseSimon C Johnson, Peter S Rabinovitch, Matt Kaeberlein
Aging Cell|June 17, 2015
Genetic evidence for common pathways in human age-related diseasesSimon C Johnson, Xiao Dong, Jan Vijg, et al.
Interdisciplinary Topics in Gerontology|October 25, 2014
Modulating mTOR in aging and healthSimon C Johnson, Maya Sangesland, Matt Kaeberlein, et al.
Science Translational Medicine|November 15, 2013
Preserving youth: does rapamycin deliver?Simon C Johnson, George M Martin, Peter S Rabinovitch, et al.
Neurotoxicology and Teratology|November 26, 2018
Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studiesSimon C Johnson, Amanda Pan, Li Li, et al.
Pageof 5